Yu Yin

620 total citations
30 papers, 374 citations indexed

About

Yu Yin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Yu Yin has authored 30 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yu Yin's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Yu Yin is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Yu Yin collaborates with scholars based in United States, China and Canada. Yu Yin's co-authors include Huamao Mark Lin, Dimitri Bennett, Yizhou Ye, Michael Camilleri, Susanna Y. Huh, Cristina Almansa, Ying Cao, Xiaoyun Pan, Mohammad Jahanzeb and Wei Han and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Yu Yin

27 papers receiving 366 citations

Peers

Yu Yin

PRM

ONCOL

GASTR

Xiaoqiao Zhang China

Hui Lian China

Zhongzheng Li China

Takao Hamamoto Japan

Xuefeng Zheng China

ROSARIA D’URSO Italy

Syed Zaidi United States

Fan Ge China

K D MacRae United Kingdom

Xiaoqiao Zhang China

Yu Yin

133 ×0.8

PRM

242 ×1.7

ONCOL

82 ×1.4

GASTR

43 ×0.8

22 ×0.4

Citations per year, relative to Yu Yin Yu Yin (= 1×) peers Xiaoqiao Zhang

Countries citing papers authored by Yu Yin

Since Specialization

Citations

This map shows the geographic impact of Yu Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yin more than expected).

Fields of papers citing papers by Yu Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yin. The network helps show where Yu Yin may publish in the future.

Co-authorship network of co-authors of Yu Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Yin. A scholar is included among the top collaborators of Yu Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Yin. Yu Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yin, Yu, et al.. (2025). Recent advances in training intensity distribution theory for cyclic endurance sports: theoretical foundations, model comparisons, and periodization characteristics. Frontiers in Physiology. 16. 1657892–1657892.

Liu, Geoffrey, Tony Mok, Alexis B. Cortot, et al.. (2025). Patterns of Treatment and Real‐World Outcomes of Patients With Non‐small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study. Cancer Medicine. 14(3). e70369–e70369.

Kopetz, Scott, et al.. (2025). A real-world study of treatment patterns among patients (pts) with metastatic colorectal cancer (mCRC) receiving third-line (3L) or fourth-line (4L) treatment in the US.. Journal of Clinical Oncology. 43(4_suppl). 64–64. 2 indexed citations

Yin, Yu, et al.. (2025). Effectiveness of long-term cluster training and traditional resistance training in enhancing maximum strength in young adults: a systematic review and meta-analysis. Frontiers in Physiology. 16. 1568247–1568247. 1 indexed citations

Arnaoutakis, Konstantinos, Jennifer Elliott, Yu Yin, et al.. (2024). Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC. Advances in Therapy. 41(8). 3217–3231. 2 indexed citations

Li, Weibo, et al.. (2023). Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model. Lymphatic Research and Biology. 21(6). 565–573. 3 indexed citations

Ou, Sai‐Hong Ignatius, Huamao Mark Lin, Jin‐Liern Hong, et al.. (2023). Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison. Lung Cancer. 179. 107186–107186. 4 indexed citations

Ou, Sai‐Hong Ignatius, Huamao Mark Lin, Jin‐Liern Hong, et al.. (2023). Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations. JTO Clinical and Research Reports. 4(10). 100558–100558. 25 indexed citations

Liu, Xiaolu, Wendong Zhang, Weibo Li, et al.. (2023). Effects of motor imagery based brain-computer interface on upper limb function and attention in stroke patients with hemiplegia: a randomized controlled trial. BMC Neurology. 23(1). 136–136. 30 indexed citations

10.

Liu, Qingqing, et al.. (2022). Correlation between focal lesion sites and language deficits in the acute phase of post-stroke aphasia. Folia Neuropathologica. 60(1). 60–68. 4 indexed citations

11.

Lin, Huamao Mark, et al.. (2022). EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States. JTO Clinical and Research Reports. 3(3). 100285–100285. 17 indexed citations

12.

Lin, Huamao Mark, Yu Yin, Huifeng Niu, et al.. (2022). Real-world ALK Testing Trends in Patients With Advanced Non–Small-Cell Lung Cancer in the United States. Clinical Lung Cancer. 24(1). e39–e49. 8 indexed citations

13.

Lee, Victor, et al.. (2022). 1111P Real-world treatment duration in patients with non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion (EGFRex20ins) mutations receiving mobocertinib through the global Expanded Access Program (EAP). Annals of Oncology. 33. S1059–S1059. 1 indexed citations

14.

Piotrowska, Zofia, et al.. (2022). 1001P Epidermal growth factor receptor (EGFR) testing and treatment patterns associated with diagnosis of non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions (ex20ins) in the US. Annals of Oncology. 33. S1011–S1011. 1 indexed citations

15.

Christopoulos, Petros, S-H.I. Ou, Jianchang Lin, et al.. (2021). 1224P Systematic review and meta-analysis of immunotherapy effectiveness for pretreated patients with non-small cell lung cancer harboring EGFR exon 20 insertions. Annals of Oncology. 32. S972–S972. 2 indexed citations

16.

Ye, Yizhou, Yu Yin, Susanna Y. Huh, et al.. (2021). Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database. Gastroenterology. 162(1). 109–121.e5. 74 indexed citations

17.

Ou, Sai‐Hong Ignatius, Huamao Mark Lin, Jin‐Liern Hong, et al.. (2021). Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.. Journal of Clinical Oncology. 39(15_suppl). 9098–9098. 20 indexed citations

18.

Jahanzeb, Mohammad, Huamao Mark Lin, Xiaoyun Pan, et al.. (2020). Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 22(1). 49–57. 47 indexed citations

19.

Yin, Yu, Wei Han, & Ying Cao. (2018). Association between activities of SOD, MDA and Na+-K+-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia. Hellenic Journal of Cardiology. 60(6). 366–371. 33 indexed citations

20.

Zhang, Xin, et al.. (2014). XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis. Tumor Biology. 35(6). 5637–5645. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact